Procedural Pharmaceutical Lessons From Early Adopters

Experienced glaucoma surgeons share practical pearls on integrating sustained drug delivery into practice.

1

Sustained-release pharmaceuticals offer a new method for glaucoma management by delivering medication directly to the eye.
2

Two FDA-approved options are Durysta, administered in-office, and iDose TR, implanted in the operating room.
3

Surgeons are refining the integration of sustained drug delivery into treatment paradigms, including as alternatives to topical medications.
4

Patient selection is crucial, with ideal candidates often already controlled on a single medication seeking to reduce drops.
5

Effective patient counseling involves discussing the benefits of sustained drug delivery to alleviate concerns about daily medication.

1